Clinical Perspectives

How Community Collaboration Helps Optimize Cancer Care Outcomes

Moffitt’s highly specialized experts alongside our community to share insights into the latest innovations and best practices so that patients in the...

GI Surgical Oncology Team Stands at the Forefront of Treatment

The surgeons in the GI Surgical Oncology group are national leaders in surgical and cancer management.

Surgical Expertise Only at Moffitt

The surgical teams at Moffitt have unparalleled skills and are familiar with treating and studying even the rarest cancers.  

Treating Benign Thyroid Nodules with Radiofrequency Ablation (RFA)

Radiofrequency ablation (RFA) employs a minimally invasive technique to treat benign thyroid nodules, attributing to a high satisfaction in patient...

Researchers Investigating TIL Therapy Feasibility in Head and Neck Squamous Cell Cancer

Dr. Kedar Kirtane is the principal investigator for a Phase IB clinical trial focusing on Squamous Cell Cancer Tumor-Infiltrating Lymphocytes (TIL).

How a CRC Enhances the Patient’s Journey at Moffitt

Clinical research coordinators at Moffitt are essential pillars in executing clinical trials.

FDA Approves CARVYKTI® and ABECMA for Early Treatment of Adult Patients with Relapsed or Refractory Multiple Myeloma

On April 5, 2024, the FDA revised the indications of both approved CAR T cell therapies for relapsed multiple myeloma to allow the use of these...

Advancements in Non-Muscle Invasive Bladder Cancer Treatment

The FDA has approved many alternative treatment methods for NMIBC, and several others are being investigated in clinical efficacy trials.

Pioneering Advances in Upper Extremity Oncologic Reconstruction and Endoprosthetic Reverse Shoulder Technology

Reverse shoulder technology is a new, promising solution that allows for improved shoulder function. At Moffitt, patients have access to a leading...

Advancements in Pancreatic Cancer Vaccines: A New Frontier in Immunotherapy Treatment

The landscape of pancreatic cancer treatment is evolving, driven by innovative approaches such as immunotherapy and pancreatic cancer vaccines.

FAQ: Revolutionizing Radiation Treatment with Proton Therapy

Moffitt is excited to partner with IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, to bring proton...

Revolutionizing Thyroid Surgeries with Autofluorescence Technology

A groundbreaking innovation leading the charge in improving surgical outcomes for thyroid and parathyroid surgeries is autofluorescence technology.

Revolutionizing Melanoma Treatment: FDA Approval for TILs Therapy Marks a Turning Point

The recent FDA approval of Lifileucel TIL therapy presents a groundbreaking advancement in the realm of solid tumor cancer treatment.

Navigating New Frontiers: Far Medial Technique in Minimally Invasive Brain Tumor Surgery

For lesions requiring surgery in the clivus region, navigating these intricate structures near the base of the brain requires high precision.

Moffitt's CARDIO-CATCH Clinic for Clonal Hematopoiesis

With a strong commitment to understanding and addressing the implications of clonal hematopoiesis mutations, Moffitt is pioneering a groundbreaking...